Reduced Susceptibility to Polyenes Associated with a Missense Mutation in the ERG6 Gene in a Clinical Isolate of Candida glabrata with Pseudohyphal Growth
Open accessAbstract
Little information is available about the molecular mechanisms responsible for polyene resistance in pathogenic yeasts. A clinical isolate of Candida glabrata with a poor susceptibility to polyenes, as determined by disk diffusion method and confirmed by determination of MIC, was recovered from a patient treated with amphotericin B. Quantitative analysis of sterols revealed a lack of ergosterol and an accumulation of late sterol intermediates, suggesting a defect in the final steps of the ergosterol pathway. Sequencing of CgERG11, CgERG6, CgERG5, and CgERG4 genes revealed exclusively a unique missense mutation in CgERG6 leading to the substitution of a cysteine by a phenylalanine in the corresponding protein. In addition, real-time reverse transcription-PCR demonstrated an overexpression of genes encoding enzymes involved in late steps of the ergosterol pathway. Moreover, this isolate exhibited a pseudohyphal growth whatever the culture medium used, and ultrastructural changes of the cell wall of blastoconidia were seen consisting in a thinner inner layer. Cell wall alterations were also suggested by the higher susceptibility of growing cells to Calcofluor white. Additionally, complementation of this isolate with a wild-type copy of the CgERG6 gene restored susceptibility to polyenes and a classical morphology. Together, these results demonstrated that mutation in the CgERG6 gene may lead to a reduced susceptibility to polyenes and to a pseudohyphal growth due to the subsequent changes in sterol content of the plasma membrane.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In another clinical isolate of Candida glabrata recovered from a patient treated with amphotericin B and with poor susceptibility to polyenes, a deficiency of ergosterol and an accumulation of late sterol intermediates was detected.
“In another clinical isolate of C. glabrata recovered from a patient treated with amphotericin B and with a poor susceptibility to polyenes, a deficiency of ergosterol and an accumulation of late sterol intermediates was detected”
From Candida glabrata Biofilms: How Far Have We Come? (2017) · cites this paper as [116]
Cites
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353 · see citing works
Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences
Sanglard, D., & Odds, F. C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00181-0 · Cited by 784 · see citing works
Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance
Krcmery, V., & Barnes, A. J. (2002) · Journal of Hospital Infection · doi:10.1053/jhin.2001.1151 · Cited by 733 · see citing works
Amphotericin B: spectrum and resistance
Ellis, D. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.suppl_1.7 · Cited by 474 · see citing works
Sanglard, D., Ischer, F., Parkinson, T., Falconer, D., & Bille, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2404-2412.2003 · Cited by 398 · see citing works
Kelly, S. L., Lamb, D. C., Kelly, D. E., Manning, N. J., Loeffler, J., Hebart, H., Schumacher, U., & Einsele, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01360-9 · Cited by 351 · see citing works
PHYSIOLOGICAL IMPLICATIONS OF STEROL BIOSYNTHESIS IN YEAST
Parks, L. W., & Casey, W. M. (1995) · Annual Review of Microbiology · doi:10.1146/annurev.mi.49.100195.000523 · Cited by 336 · see citing works
Antifungal Resistance in Pathogenic Fungi
Perea, S. H., & Patterson, T. F. (2002) · Clinical Infectious Diseases · doi:10.1086/344058 · Cited by 286 · see citing works
Gaber, R. F., Copple, D. M., Kennedy, B. K., Vidal, M., & Bard, M. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.8.3447 · Cited by 257 · see citing works
Vermitsky, J., Earhart, K. D., Smith, W. L., Homayouni, R., Edlind, T. D., & Rogers, P. D. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05235.x · Cited by 233 · see citing works
Ergosterol is required for targeting of tryptophan permease to the yeast plasma membrane
Umebayashi, K., & Nakano, A. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200303088 · Cited by 230 · see citing works
Nolte, F. S., Parkinson, T., Falconer, D. J., Dix, S. P., Williams, J. M., Gilmore, C., Geller, R., & Wingard, J. R. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.1.196 · Cited by 219 · see citing works
Lees, N. D., Skaggs, B., Kirsch, D. R., & Bard, M. (1995) · Lipids · doi:10.1007/bf02537824 · Cited by 202 · see citing works
Disruption of Ergosterol Biosynthesis Confers Resistance to Amphotericin B inCandida lusitaniae
Young, L. Y., Hull, C. M., & Heitman, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2717-2724.2003 · Cited by 184 · see citing works
Tronchin, G., Bouchara, J. P., Robert, R., & Senet, J.-M. (1988) · Infection and Immunity · doi:10.1128/iai.56.8.1987-1993.1988 · Cited by 152 · see citing works
Self-citationMechanisms of Azole Resistance in Petite Mutants of <i>Candida glabrata</i>
Brun, S., Bergès, T., Poupard, P., Vauzelle-Moreau, C., Renier, G., Chabasse, D., & Bouchara, J.-P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1788-1796.2004 · Cited by 151 · see citing works
Self-citationCloning, disruption and sequence of the gene encoding yeast C-5 sterol desaturase
Arthington, B. A., Bennett, L. G., Skatrud, P. L., Guynn, C. J., Barbuch, R. J., UIbright, C. E., & Bard, M. (1991) · Gene · doi:10.1016/0378-1119(91)90535-j · Cited by 149 · see citing works
Mechanisms of Azole Resistance in a Clinical Isolate of Candida tropicalis
Vandeputte, P., Larcher, G., Bergès, T., Rénier, G., Chabasse, D., & Bouchara, J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4608-4615.2005 · Cited by 141 · see citing works
Self-citationAntibiotic resistance surveillance: action for international studies
Morris, A. K. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.1.7 · Cited by 136 · see citing works
<i>Candida glabrata</i>displays pseudohyphal growth
Csank, C., & Haynes, K. (2000) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2000.tb09216.x · Cited by 129 · see citing works
Jensen-Pergakes, K. L., Kennedy, M. A., Lees, N. D., Barbuch, R., Koegel, C., & Bard, M. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1160 · Cited by 121 · see citing works
8 Regulation and Compartmentalization of Lipid Synthesis in YeastPreprint
Paltauf, F., Kohlwein, S. D., & Henry, S. A. (1992) · Cold Spring Harbor Monograph Archive · doi:10.1101/0.415-500 · Cited by 120 · see citing works
Barker, K. S. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh336 · Cited by 117 · see citing works
Regulation of early enzymes of ergosterol biosynthesis in Saccharomyces cerevisiae
Servouse, M., & Karst, F. (1986) · Biochemical Journal · doi:10.1042/bj2400541 · Cited by 113 · see citing works
Graham, T. R., Scott, P. A. E., & Emr, S. D. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05727.x · Cited by 105 · see citing works
Phenotypic switching and filamentation in Candida glabrata
Lachke, S. A., Joly, S., Daniels, K., & Soll, D. R. (2002) · Microbiology · doi:10.1099/00221287-148-9-2661 · Cited by 103 · see citing works
Transcriptional Regulation by Ergosterol in the Yeast Saccharomyces cerevisiae
Smith, S. J., Crowley, J. H., & Parks, L. W. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.10.5427 · Cited by 91 · see citing works
Spectrum of opportunistic infections in AIDS cases.
Singh, A. P., Bairy, I., & Shivananda, P. G. (2003) · PubMed · Cited by 87 · see citing works
Cloning and disruption of the yeast C‐8 sterol isomerase gene
Ashman, W. H., Barbuch, R. J., Ulbright, C. E., Jarrett, H. W., & Bard, M. (1991) · Lipids · doi:10.1007/bf02536427 · Cited by 79 · see citing works
Gaber, R. F., Copple, D. M., Kennedy, B. K., Vidal, M., & Bard, M. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.8.3447-3456.1989 · Cited by 78 · see citing works
Calcagno-Pizarelli, A. M., Bignell, E., Warn, P. A., Jones, M. D., Denning, D. W., Mühlschlegel, F. A., Rogers, T. R., & Haynes, K. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03755.x · Cited by 70 · see citing works
Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance
Niimi, M., Niimi, K., Takano, Y., Holmes, A. R., Fischer, F. J., Uehara, Y., & Cannon, R. D. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh456 · Cited by 69 · see citing works
Lorenz, R. T., & Parks, L. W. (1992) · DNA and Cell Biology · doi:10.1089/dna.1992.11.685 · Cited by 67 · see citing works
In-vitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata
DEFONTAINE, A., BOUCHARA, J.-P., DECLERK, P., PLANCHENAULT, C., CHABASSE, D., & HALLET, J.-N. (1999) · Journal of Medical Microbiology · doi:10.1099/00222615-48-7-663 · Cited by 65 · see citing works
Self-citationRelationships between Respiration and Susceptibility to Azole Antifungals in <i>Candida glabrata</i>
Brun, S., Aubry, C., Lima, O., Filmon, R., Bergès, T., Chabasse, D., & Bouchara, J.-P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.847-853.2003 · Cited by 64 · see citing works
Self-citationCandida glabrata erg1 Mutant with Increased Sensitivity to Azoles and to Low Oxygen Tension
Tsai, H., Bard, M., Izumikawa, K., Krol, A. A., Sturm, A. M., Culbertson, N. T., Pierson, C. A., & Bennett, J. E. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2483-2489.2004 · Cited by 56 · see citing works
AIDS-Related Opportunistic Infections in Hospital Kuala Lumpur
Nissapatorn, V., Lee, C., Quek, K. F., & Abdullah, K. A. (2003) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2003.187 · Cited by 49 · see citing works
Isolation and analysis of ketoconazole resistant mutants ofSaccharomyces cerevisiae
Watson, P. F., Rose, M. E., & Kelly, S. L. (1988) · Medical Mycology · doi:10.1080/02681218880000231 · Cited by 45 · see citing works
Smith, S. J., & Parks, L. W. (1993) · Yeast · doi:10.1002/yea.320091104 · Cited by 44 · see citing works
Hemmi, K., Julmanop, C., Hirata, D., Tsuchiya, E., Takemoto, J. Y., & Miyakawa, T. (1995) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.59.482 · Cited by 43 · see citing works
Taguchi, N., Takano, Y., Julmanop, C., Wang, Y., Stock, S., Takemoto, J. Y., & Miyakawa, T. (1994) · Microbiology · doi:10.1099/13500872-140-2-353 · Cited by 42 · see citing works
Odds, F. C., Rinaldi, M. G., Cooper, C. R., Fothergill, A., Pasarell, L., & McGinnis, M. R. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.1.313-316.1997 · Cited by 24 · see citing works
Effect of sterol side-chain structure on the feed-back control of sterol biosynthesis in yeast
Casey, W., Burgess, J. P., & Parks, L. W. (1991) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(91)90283-n · Cited by 23 · see citing works
Mutations sensitizing yeast cells to the start inhibitor nalidixic acid
Prendergast, J. A., Singer, R. A., Rowley, N., Rowley, A., Johnston, G. C., Danos, M. C., Kennedy, B., & Gaber, R. F. (1995) · Yeast · doi:10.1002/yea.320110603 · Cited by 21 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Silva, S., Negri, M., Henriques, M., Oliveira, R., Williams, D. W., & Azeredo, J. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00278.x · Cited by 969 · see citing works
Regulatory circuitry governing fungal development, drug resistance, and disease.
Shapiro, R. S., Robbins, N., & Cowen, L. E. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00045-10 · Cited by 576 · see citing works
Antifungal Resistance and New Strategies to Control Fungal Infections
Vandeputte, P., Ferrari, S., & Coste, A. T. (2011) · International Journal of Microbiology · doi:10.1155/2012/713687 · Cited by 507 · see citing works
Self-citationMechanisms of <i>Candida</i> Biofilm Drug Resistance
Taff, H. T., Mitchell, K. F., Edward, J. A., & Andes, D. R. (2013) · Future Microbiology · doi:10.2217/fmb.13.101 · Cited by 422 · see citing works
Spampinato, C., & Leonardi, D. (2013) · BioMed Research International · doi:10.1155/2013/204237 · Cited by 411 · see citing works
It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug
Mesa-Arango, A. C., Scorzoni, L., & Zaragoza, O. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00286 · Cited by 311 · see citing works
Regulation of multidrug resistance in pathogenic fungi
Morschhäuser, J. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.08.002 · Cited by 300 · see citing works
An Update on Candida tropicalis Based on Basic and Clinical Approaches
Zuza-Alves, D. L., Rocha, W. P. D. S., & Chaves, G. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01927 · Cited by 305 · see citing works
Sanglard, D., Coste, A., & Ferrari, S. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00578.x · Cited by 285 · see citing works
Healey, K. R., Zhao, Y., Perez, W. B., Lockhart, S. R., Sobel, J. D., Farmakiotis, D., Kontoyiannis, D. P., Sanglard, D., Taj-Aldeen, S. J., Alexander, B. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms11128 · Cited by 276 · see citing works
Candida glabrata: A review of its features and resistance
Rodrigues, C. F., Silva, S., & Henriques, M. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-2009-3 · Cited by 268 · see citing works
Mesa-Arango, A. C., Trevijano-Contador, N., Román, E., Sánchez-Fresneda, R., Casas, C., Herrero, E., Argüelles, J. C., Pla, J., Cuenca-Estrella, M., & Zaragoza, O. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03570-14 · Cited by 232 · see citing works
Carolus, H., Pierson, S., Muñoz, J. F., Subotić, A., Cruz, R. B., Cuomo, C. A., & Van Dijck, P. (2021) · mBio · doi:10.1128/mbio.03333-20 · Cited by 211 · see citing works
Schwarzmüller, T., Ma, B., Hiller, E., Istel, F., Tscherner, M., Brunke, S., Ames, L., Firon, A., Green, B., Cabral, V., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004211 · Cited by 191 · see citing works
Antifungals: Mechanism of Action and Drug Resistance
Prasad, R., Shah, A. H., & Rawal, M. K. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-25304-6_14 · Cited by 185 · see citing works
Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus
Gonçalves, S. S., Souza, A. C. R., Chowdhary, A., Meis, J. F. G. M., & Colombo, A. L. (2016) · Mycoses · doi:10.1111/myc.12469 · Cited by 182 · see citing works
Emerging multidrug-resistant Candida species
Colombo, A. L., Júnior, J. N. D. A., & Guinea, J. (2017) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000411 · Cited by 177 · see citing works
Geddes‐McAlister, J., & Shapiro, R. S. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13739 · Cited by 159 · see citing works
Mecanismos de resistencia a los antifúngicos: levaduras y hongos filamentosos
Espinel‐Ingroff, A. (2008) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(08)70027-5 · Cited by 139 · see citing works
Candida glabrata Biofilms: How Far Have We Come?
Rodrigues, C., Rodrigues, M., Silva, S., & Henriques, M. (2017) · Journal of Fungi · doi:10.3390/jof3010011 · Cited by 129 · see citing works
Candida glabrata: A Lot More Than Meets the Eye
Kumar, K., Askari, F., Sahu, M. S., & Kaur, R. (2019) · Microorganisms · doi:10.3390/microorganisms7020039 · Cited by 128 · see citing works
Antifungal drug resistance mechanisms
Pemán, J., Cantón, E., & Espinel‐Ingroff, A. (2009) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.18 · Cited by 121 · see citing works
Vandeputte, P., Tronchin, G., Larcher, G., Ernoult, E., Bergès, T., Chabasse, D., & Bouchara, J.-P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00423-08 · Cited by 117 · see citing works
Self-citationHull, C. M., Parker, J. E., Bader, O., Weig, M., Gross, U., Warrilow, A. G. S., Kelly, D. E., & Kelly, S. L. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06253-11 · Cited by 113 · see citing works
Elucidating Drug Resistance in Human Fungal Pathogens
Xie, J. L., Polvi, E. J., Shekhar‐Guturja, T., & Cowen, L. E. (2014) · Future Microbiology · doi:10.2217/fmb.14.18 · Cited by 98 · see citing works
Spaceflight Enhances Cell Aggregation and Random Budding in Candida albicans
Crabbé, A., Nielsen‐Preiss, S. M., Woolley, C. M., Barrila, J., Buchanan, K. L., McCracken, J., Inglis, D. O., Searles, S. C., Nelman-Gonzalez, M. A., Ott, C. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080677 · Cited by 94 · see citing works
Hull, C. M., Bader, O., Parker, J. E., Weig, M., Gross, U., Warrilow, A. G. S., Kelly, D. E., & Kelly, S. L. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01145-12 · Cited by 90 · see citing works
Mesa-Arango, A. C., Rueda, C., Román, E., Quintin, J., Terrón, M. C., Luque, D., Netea, M. G., Pla, J., & Zaragoza, O. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02681-15 · Cited by 86 · see citing works
Ahmad, S., Joseph, L., Parker, J. E., Asadzadeh, M., Kelly, S. L., Meis, J. F. G. M., & Khan, Z. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01900-18 · Cited by 83 · see citing works
Cierech, M., Kolenda, A., Grudniak, A., Wojnarowicz, J., Woźniak, B., Gołaś, M., Swoboda‐Kopeć, E., Łojkowski, W., & Mierzwińska‐Nastalska, E. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.06.052 · Cited by 78 · see citing works
Antifungal use influences Candida species distribution and susceptibility in the intensive care unit
Fournier, P., Schwebel, C., Maubon, D., Vesin, A., Lebeau, B., Foroni, L., Hamidfar-Roy, R., Cornet, M., Timsit, J., & Pelloux, H. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr394 · Cited by 76 · see citing works
Tipping the balance both ways: drug resistance and virulence in Candida glabrata
Vale-Silva, L. A., & Sanglard, D. (2015) · FEMS Yeast Research · doi:10.1093/femsyr/fov025 · Cited by 68 · see citing works
Linking Cellular Morphogenesis with Antifungal Treatment and Susceptibility in Candida Pathogens
Sharma, J., Rosiana, S., Razzaq, I., & Shapiro, R. S. (2019) · Journal of Fungi · doi:10.3390/jof5010017 · Cited by 64 · see citing works
Evaluation of the antimicrobial activity of ebselen: Role of the yeast plasma membrane H+‐ATPase
Chan, G., Hardej, D., Santoro, M., Lau‐Cam, C. A., & Billack, B. (2007) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.20189 · Cited by 64 · see citing works
Brunke, S., Seider, K., Fischer, D., Jacobsen, I. D., Kasper, L., Jablonowski, N., Wartenberg, A., Bader, O., Angoulvant, A., Schaller, M., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004478 · Cited by 62 · see citing works
In search of the holy grail of antifungal therapy.
Chapman, S. W., Sullivan, D. C., & Cleary, J. D. (2008) · PubMed Central · Cited by 64 · see citing works
Ergosterol Biosynthesis and Regulation Impact the Antifungal Resistance and Virulence of Candida spp
Eliaš, D., Tóth Hervay, N., & Gbelská, Y. (2024) · Stresses · doi:10.3390/stresses4040041 · Cited by 63 · see citing works
Molecular Mechanisms of Resistance to 5-Fluorocytosine in Laboratory Mutants of Candida glabrata
Vandeputte, P., Pineau, L., Larcher, G., Noel, T., Brèthes, D., Chabasse, D., & Bouchara, J.-P. (2011) · Mycopathologia · doi:10.1007/s11046-010-9342-1 · Cited by 55 · see citing works
Self-citationAntifungal drug resistance in Candida: a special emphasis on amphotericin B
Ahmady, L., Gothwal, M., Mukkoli, M. M., & Bari, V. K. (2024) · Apmis · doi:10.1111/apm.13389 · Cited by 58 · see citing works
Salazar, S. B., Simões, R., Pedro, N. A., Pinheiro, M. J. F., Carvalho, M. F. N. N., & Mira, N. P. (2020) · Journal of Fungi · doi:10.3390/jof6010023 · Cited by 55 · see citing works
Erg6 affects membrane composition and virulence of the human fungal pathogen Cryptococcus neoformans
de Oliveira, F. F. M., Paes, H. C., Peconick, L. D. F., Fonseca, F. L., Marina, C. L., Bocca, A. L., Homem-de-Mello, M., Rodrigues, M. L., Albuquerque, P., Nicola, A. M., et al. (2020) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2020.103368 · Cited by 50 · see citing works
Reconstruction and analysis of the genome-scale metabolic network of Candida glabrata
Xu, N., Liu, L., Zou, W., Liu, J., Hua, Q., & Chen, J. (2012) · Molecular BioSystems · doi:10.1039/c2mb25311a · Cited by 49 · see citing works
Angoulvant, A., Guitard, J., & Hennequin, C. (2015) · FEMS Yeast Research · doi:10.1093/femsyr/fov114 · Cited by 45 · see citing works
Self-citationRodrigues, C. F., & Henriques, M. (2017) · Pathogens · doi:10.3390/pathogens6040062 · Cited by 47 · see citing works
Novel point mutations in the ERG11 gene in clinical isolates of azole resistant Candida species
Silva, D. B. D. S., Rodrigues, L. M. C., Almeida, A. A. D., Oliveira, K. M. P. D., & Grisolia/, A. B. (2016) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760150400 · Cited by 42 · see citing works
An Introduction to the Medically Important Candida Species
Moran, G. P., Coleman, D. C., & Sullivan, D. J. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch2 · Cited by 50 · see citing works
Gênero Candida - Fatores de virulência, Epidemiologia, Candidíase e Mecanismos de resistência
da Rocha, W. R. V., Nunes, L. E., Neves, M. L. D. R., Ximenes, E. A., & Albuquerque, M. C. P. D. A. (2021) · Research Society and Development · doi:10.33448/rsd-v10i4.14283 · Cited by 43 · see citing works
Targeting Candida spp. to develop antifungal agents
Salci, T. P., Negri, M., Abadio, A. K. R., Svidzinski, T. I. E., & Kioshima, É. S. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.003 · Cited by 35 · see citing works
Resistance to antifungal therapies
Prasad, R., Banerjee, A., & Shah, A. H. (2017) · Essays in Biochemistry · doi:10.1042/ebc20160067 · Cited by 33 · see citing works
Changing epidemiology of non-albicans candidemia in Korea
Ko, J., Jung, D. S., Lee, J. Y., Kim, H. A., Ryu, S. Y., Jung, S., Joo, E., Cheon, S., Ys, K., Kim, S., et al. (2018) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2018.09.016 · Cited by 31 · see citing works
Gubbins, P. O., & Anaissie, E. J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5680-5.00007-4 · Cited by 29 · see citing works
Future therapies targeted towards eliminatingCandidabiofilms and associated infections
Bandara, N., Matsubara, V. H., & Samaranayake, L. P. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1268530 · Cited by 29 · see citing works
Vandeputte, P., Tronchin, G., Rocher, F., Renier, G., Bergès, T., Chabasse, D., & Bouchara, J.-P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01384-08 · Cited by 26 · see citing works
Self-citationCombination of Posaconazole and Amphotericin B in the Treatment of Candida glabrata Biofilms
Rodrigues, C. F., Alves, D. F., & Henriques, M. (2018) · Microorganisms · doi:10.3390/microorganisms6040123 · Cited by 25 · see citing works
Antifungal Resistance Mechanisms of Aspergillus
Qiao, J., Liu, W. Y., & Li, R. (2008) · Nippon Ishinkin Gakkai Zasshi · doi:10.3314/jjmm.49.157 · Cited by 26 · see citing works
The Microevolution of Antifungal Drug Resistance in Pathogenic Fungi
Boyce, K. J. (2023) · Microorganisms · doi:10.3390/microorganisms11112757 · Cited by 25 · see citing works
ERG6gene deletion modifiesKluyveromyces lactissusceptibility to various growth inhibitors
Konecna, A., Hervay, N. T., Valachovič, M., & Gbelská, Y. (2016) · Yeast · doi:10.1002/yea.3212 · Cited by 23 · see citing works
Amphotericin B: Polyene Resistance Mechanisms
O’Shaughnessy, E. M., Lyman, C. A., & Walsh, T. J. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-180-2_25 · Cited by 23 · see citing works
Demin, K. A., Refeld, A. G., Bogdanova, A. A., Prazdnova, E. V., Popov, I. V., Kutsevalova, O. Y., Ermakov, A. M., Bren, A. B., Rudoy, D. V., Chistyakov, V. A., et al. (2021) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-021-09776-6 · Cited by 24 · see citing works
Eliaš, D., Hervay, N. T., Jacko, J., Morvová, M., Valachovič, M., & Gbelská, Y. (2022) · FEMS Yeast Research · doi:10.1093/femsyr/foac045 · Cited by 21 · see citing works
Candida glabrata, Friend and Foe
Tam, P., Gee, K., Piechocinski, M., & Macreadie, I. G. (2015) · Journal of Fungi · doi:10.3390/jof1020277 · Cited by 22 · see citing works
Regulation of ERG3, ERG6, and ERG11 Genes in Antifungal-Resistant isolates of Candida parapsilosis
Lotfali, E., Ghajari, A., Kordbacheh, P., Zaini, F., Mirhendi, H., Mohammadi, R., Noorbakhsh, F., & Rezaie, S. (2017) · Iranian Biomedical Journal · doi:10.18869/acadpub.ibj.21.4.275 · Cited by 22 · see citing works
Foglia, F., Drake, A. F., Terry, A. E., Rogers, S. E., Lawrence, M. J., & Barlow, D. J. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.02.012 · Cited by 19 · see citing works
Effect of Voriconazole on Candida tropicalis Biofilms: Relation with ERG Genes Expression
Fernandes, T., Silva, S. M., & Henriques, M. (2016) · Mycopathologia · doi:10.1007/s11046-016-0023-6 · Cited by 19 · see citing works
Sun, J., Zhang, T., Li, Y., Wang, X., & Chen, J. (2018) · Biological Control · doi:10.1016/j.biocontrol.2018.10.004 · Cited by 19 · see citing works
Recent innovations and challenges in the treatment of fungal infections
Liu, D., Zhou, R., & Gao, X. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1676009 · Cited by 23 · see citing works
Antimycotic Drugs and their Mechanisms of Resistance to Candida Species
Dahiya, S., Sharma, N., Punia, A., Choudhary, P., Gulia, P., Parmar, V. S., & Chhillar, A. K. (2021) · Current Drug Targets · doi:10.2174/1389450122666210719124143 · Cited by 19 · see citing works
Lotfali, E., Fattahi, A., Sayyahfar, S., Ghasemi, R., Rabiei, M. M., Fathi, M., Vakili, K. G., Deravi, N., Soheili, A., Toreyhi, H., et al. (2021) · Microbial Drug Resistance · doi:10.1089/mdr.2020.0235 · Cited by 17 · see citing works
Pfaller, M. A., Castanheira, M., Lockhart, S. R., & Jones, R. N. (2012) · Current Fungal Infection Reports · doi:10.1007/s12281-012-0091-0 · Cited by 17 · see citing works
Lim, H. J., Choi, M. J., Byun, S. A., Won, E. J., Park, J.-H., Choi, Y. J., Choi, H., Choi, H.-W., Kee, S., Kim, S. H., et al. (2023) · Journal of Fungi · doi:10.3390/jof9050515 · Cited by 15 · see citing works
Genome-Wide Response to Drugs and Stress in the Pathogenic Yeast Candida glabrata
Pais, P., Galocha, M., & Teixeira, M. C. (2019) · Progress in molecular and subcellular biology · doi:10.1007/978-3-030-13035-0_7 · Cited by 16 · see citing works
Amphotericin B-copper(II) complex shows improved therapeutic index in vitro
Chudzik, B., Czernel, G., Miaskowski, A., & Gagoś, M. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.10.040 · Cited by 14 · see citing works
Asadzadeh, M., Alfouzan, W. A., Parker, J. E., Meis, J. F. G. M., Kelly, S. L., Joseph, L., & Ahmad, S. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01474-23 · Cited by 15 · see citing works
Candida Biofilm Tolerance: Comparison of Planktonic and Biofilm Resistance Mechanisms
Dominguez, E. G., & Andes, D. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_6 · Cited by 13 · see citing works
Castillo-Castañeda, A. C., Cañas-Duarte, S. J., Guevara‐Suarez, M., Guarro, J., Restrepo, S., & Ramírez, A. M. C. (2020) · Microbiology · doi:10.1099/mic.0.000927 · Cited by 13 · see citing works
Mechanisms of Drug Resistance in Fungi and Their Significance in Biofilms
Prasad, R., Shah, A. H., & Dhamgaye, S. (2014) · Springer series on biofilms · doi:10.1007/978-3-642-53833-9_4 · Cited by 13 · see citing works
Antifungal Targets, Mechanisms of Action, and Resistance in Candida albicans
Akins, R. A., & Sobel, J. D. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-180-2_29 · Cited by 12 · see citing works
Lu, Y., Zhou, Z., Mo, L., Guo, Q., Peng, X., Hu, T., Zhou, X., Ren, B., & Xu, X. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-09960-3 · Cited by 12 · see citing works
Naskar, S., Prajapati, A., & Kaur, R. (2025) · FEMS Yeast Research · doi:10.1093/femsyr/foaf025 · Cited by 11 · see citing works
Foglia, F., Rogers, S. E., Webster, J. R. P., Akeroyd, F., Gascoyne, K. F., Lawrence, M. J., & Barlow, D. J. (2015) · Langmuir · doi:10.1021/acs.langmuir.5b01365 · Cited by 11 · see citing works
Khan, Z., Ahmad, S., Al‐Sweih, N., Mokaddas, E. M., Al-Banwan, K., Alfouzan, W. A., Al‐Obaid, I., Alobaid, K., & Varghese, S. (2020) · Microbial Drug Resistance · doi:10.1089/mdr.2019.0437 · Cited by 11 · see citing works
Amphotericin B: Polyene Resistance Mechanisms
McCarthy, M. W., O’Shaughnessy, E. M., & Walsh, T. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-46718-4_26 · Cited by 10 · see citing works
Molecular investigations on Candida glabrata clinical isolates for pharmacological targeting
Gupta, H., Gupta, P., Kairamkonda, M., & Poluri, K. M. (2022) · RSC Advances · doi:10.1039/d2ra02092k · Cited by 9 · see citing works
Hady, R. E., Fattouh, N., Finianos, M., Bitar, I., Fakih, T., Husni, R., & Khalaf, R. A. (2025) · Scientific Reports · doi:10.1038/s41598-024-84535-5 · Cited by 9 · see citing works
Kordalewska, M., Guerrero, K. D., Mikulski, T. D., Elias, T. N., Garcia‐Rubio, R., Berrío, I., Gardam, D. J., Heath, C. H., Chowdhary, A., Govender, N. P., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.22.465535 · Cited by 8 · see citing works
Merdan, O., Şişman, A. S., Aksoy, S. A., Kızıl, S., Tüzemen, N. Ü., Yılmaz, E., & Ener, B. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00776-22 · Cited by 6 · see citing works
Post-transcriptional control of antifungal resistance in human fungal pathogens
Sharma, C., & Kadosh, D. (2023) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2080527 · Cited by 6 · see citing works
Chauhan, A., Gow, N. A. R., & Prasad, R. (2026) · The Cell Surface · doi:10.1016/j.tcsw.2026.100168 · Cited by 6 · see citing works
Ibe, C., Otu, A. A., & Pohl, C. H. (2025) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2024.2448844 · Cited by 6 · see citing works
Antifungal drug resistance: Significance and mechanisms
Dharmaiah, S., Sherif, R., & Mukherjee, P. K. (2019) · CRC Press eBooks · doi:10.1201/9780429402012-4 · Cited by 6 · see citing works
Tian, Y., Gao, N., Ni, Q., Mao, Y., Dong, D., Huang, X., Jiang, C., Li, Z., Zhang, L., Wang, X., et al. (2018) · FEMS Yeast Research · doi:10.1093/femsyr/foy038 · Cited by 6 · see citing works
Antifungal Resistance: Cellular and Molecular Mechanisms
Araújo, R., & Espinel‐Ingroff, A. (2010) · Springer eBooks · doi:10.1007/978-3-642-12173-9_7 · Cited by 5 · see citing works
Mécanismes moléculaires de la résistance aux antifongiques chez candida glabrata
Vandeputte, P. (2008) · HAL · Cited by 5 · see citing works
Self-citationEvolution of antimicrobial drug resistance in human pathogenic fungi
Mir, M. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-96127-1.00009-7 · Cited by 4 · see citing works
Narayanan, A., Shaji, A. A., Pullepu, D., Bhattacharya, J., & Sanyal, K. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5c00081 · Cited by 3 · see citing works
Resistance to Antifungal Drugs
Sanglard, D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6640-7_9 · Cited by 3 · see citing works
Angelini, J., Ferin, S., Martini, L., Flammini, S., Tascini, C., & Giuliano, S. (2026) · Clinical Microbiology Reviews · doi:10.1128/cmr.00228-25 · Cited by 2 · see citing works
Mukherjee, P. K., & Wang, M. (2009) · CRC Press eBooks · doi:10.3109/9780849387869-5 · Cited by 2 · see citing works
Fournier, P. (2011) · HAL · Cited by 1 · see citing works
Memon, S., Ghanchi, N. K., Zafar, U., Farooqi, J. Q., Zaka, S., & Jabeen, K. (2025) · Access Microbiology · doi:10.1099/acmi.0.000952.v6 · Cited by 1 · see citing works
- Authors
- Vandeputte, P., Tronchin, G., Bergès, T., Hennequin, C., Chabasse, D., & Bouchara, J.-P.
- Affiliations
- Centre Hospitalier Universitaire d'Angers (FR)
- Laboratoire de Génétique de la Levure, CNRS UMR 6161, Faculté des Sciences, 86022 Poitiers Cedex
- Hôpital Tenon (FR)
- Corresponding author
- Vandeputte, Patrick
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2007-03
- Volume
- 51
- Issue
- 3
- Pages
- 982-990
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC1803144
- OpenAlex
- W2122550330
- Cited by
- 109
- References
- 44
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 2 · 2023: 4 · 2022: 6 · 2021: 6 · 2020: 5 · 2019: 5 · 2018: 8 · 2017: 9 · 2016: 11 · 2015: 5 · 2014: 6 · 2013: 4 · 2012: 5
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Yeasts and Rust Fungi Studies
- Keywords
- Candida glabrata, polyene resistance, missense mutations, ergosterol biosynthesis, sterol intermediates, pseudohyphal growth, cell wall ultrastructure, amphotericin B, gene complementation, antifungal resistance
- MeSH terms
- Antifungal Agents, Candidiasis, Genes, Fungal, Genetic Complementation Test, Methyltransferases, Microbial Sensitivity Tests, Molecular Sequence Data, Phenotype, Polyenes, RNA, Fungal, RNA, Messenger, Sterols, DNA Primers, Mutation, Missense, Reverse Transcriptase Polymerase Chain Reaction, Candida glabrata
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review